ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,161Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 29

$510K Total Retail Price of All Prescriptions

Rank: 16 out of 29

584 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,116 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 560 560 1 1
SIMVASTATIN 468 468 2 4
LISINOPRIL 436 436 3 2
AMLODIPINE BESYLATE 338 338 4 5
OMEPRAZOLE 334 334 5 8
ATENOLOL 250 250 6 23
HYDROCHLOROTHIAZIDE 240 239 7 20
HYDROCODONE-ACETAMINOPHEN 222 222 S3 8 7
POTASSIUM CHLORIDE 221 221 9 6
ATORVASTATIN CALCIUM 200 200 10 25
CITALOPRAM HBR 198 198 11 11
FUROSEMIDE 187 187 12 3
METOPROLOL SUCCINATE 187 187 12 16
METOPROLOL TARTRATE 159 159 14 15
DIOVAN 138 138 15 35
METFORMIN HCL 133 133 16 19
TRAMADOL HCL 132 132 17 24
MIRTAZAPINE 131 131 18 13
PRAVASTATIN SODIUM 119 119 19 18
LOSARTAN POTASSIUM 115 115 20 28
ESCITALOPRAM OXALATE 108 108 21 37
GABAPENTIN 106 106 22 10
SERTRALINE HCL 103 103 23 17
NEXIUM 99 99 24 47
METFORMIN HCL ER 97 97 25 129
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 92 26 64
TRIAMTERENE-HCTZ 89 89 27 48
NAMENDA 85 85 28 12
SYNTHROID 83 83 29 52
CRESTOR 79 79 30 62
BENAZEPRIL HCL 77 77 31 83
MELOXICAM 77 77 31 36
DIGOXIN 76 76 33 34
GLIPIZIDE ER 74 74 34 146
ALENDRONATE SODIUM 74 74 34 26
CARVEDILOL 72 72 36 27
ADVAIR DISKUS 69 69 37 68
EVISTA 68 68 38 55
SINGULAIR 64 64 39 183
WARFARIN SODIUM 64 64 39 14
ZOLPIDEM TARTRATE 63 59 41 30
CLOPIDOGREL 63 63 41 33
ESTRADIOL 62 62 R 43 187
KLOR-CON M20 62 61 43 57
DILTIAZEM 24HR CD 62 62 43 109
PREDNISONE 61 61 46 41
CELEBREX 60 60 47 106
CARBIDOPA-LEVODOPA 60 60 47 42
LOVASTATIN 60 60 47 101
TRAZODONE HCL 59 59 50 22
DONEPEZIL HCL 59 59 50 9
ENALAPRIL MALEATE 57 57 52 72
PLAVIX 56 56 53 51
FAMOTIDINE 55 55 54 61
LYRICA 55 55 54 67
SPIRONOLACTONE 52 52 56 54
FLUTICASONE PROPIONATE 50 50 57 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.